REVELATION BIOSCIENCES INC (REVB) Stock Income Statement
NASDAQ:REVB - Nasdaq - US76135L6065 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 7.98M | 8.66M | 10.86M | 11.95M | 2.53M | |||
| Research and Development | 3.55M | 4.15M | 5.38M | 6.91M | 1.71M | |||
| Selling, General, and Administrative Expenses | 4.43M | 4.51M | 5.49M | 5.04M | 823.20K | |||
| Operating Income | -7.98M | -8.66M | -10.86M | -11.95M | -2.53M | |||
| Interest Income/Expense | N/A | N/A | N/A | -52.00K | 9.08K | |||
| Other Income/Expense | -7.06M | 8.54M | 35.00K | -36.40K | 100.00 | |||
| Income Before Taxes | -15.04M | -120.20K | -10.83M | -11.99M | -2.53M | |||
| Income Tax | N/A | N/A | N/A | 0.00 | N/A | |||
| Net Income | -15.04M | -120.20K | -10.83M | -11.99M | -2.53M | |||
| EBITDA | -7.95M | -8.63M | -10.84M | -11.93M | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -87.68 | -0.53 | -601.63 | -535.12 | -112.96 | |||
| Non GAAP EPS | -139.86 | 55.27 | -735.60 | N/A | N/A | |||
| Statistics | ||||||||
All data in USD